UniFirst (UNF): Evaluating Valuation as Proxy Battle Heats Up Over Board Control and Strategic Future

Simply Wall St · 4d ago

UniFirst, a company known for workplace uniform and safety solutions, is navigating a heated proxy contest just weeks ahead of its annual shareholder meeting. Recent activist campaigns have sparked debate over control of the board and the company’s long-term direction.

See our latest analysis for UniFirst.

UniFirst’s shares have recently picked up steam, climbing 14.8% over the past month to $177.15, even as a high-profile proxy battle dominates headlines. Despite the short-term bounce in share price, the company’s total shareholder return remains negative over the past year and continues to lag broader benchmarks. This suggests momentum is building, but a sustained turnaround is still to be proven.

If this proxy contest has you watching for shifts in market leadership, it might be a great opportunity to broaden your perspective and discover fast growing stocks with high insider ownership

With UniFirst's underlying performance showing only modest growth and activist pressure mounting, the question for investors remains clear: are shares undervalued given the strategic uncertainty, or is the market already pricing in future gains?

Most Popular Narrative: 7% Overvalued

With UniFirst closing at $177.15, the most widely tracked narrative assigns a fair value of $165.50 per share, suggesting the stock currently trades at a noticeable premium. This valuation is based on projected earnings growth, margin trends, and a steady discount rate to support its conclusions.

Significant investments in technology, specifically an ERP system, are anticipated to enhance efficiency. These upgrades are expected to improve profitability and reduce operational costs once fully implemented, with the potential to positively influence net margins over time. The expansion of the distribution center in Owensboro, Kentucky, is expected to increase speed and efficiency in direct sales of uniforms, which may drive revenue growth through enhanced operational capacity.

Read the complete narrative.

Curious about the hidden drivers behind this premium? The narrative focuses on bold operational shifts and margin improvements to support its price view. What specific margin and revenue forecasts justify the current premium? Find out which key assumptions shape the fair value and explore the quantitative foundation of this market view.

Result: Fair Value of $165.50 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, risks such as declining customer demand and rising healthcare costs could quickly challenge the bullish narrative and change the company's outlook.

Find out about the key risks to this UniFirst narrative.

Another View: Market Ratios Tell a Different Story

Comparing UniFirst's price-to-earnings ratio of 21.6x to industry peers, we find it looks like a relative bargain. The peer average stands at 35.4x, and the broader industry sits at 22.8x. Yet, this is still a premium over its estimated fair ratio of 19.7x, signaling that valuation risk remains. Does this market pricing hint at hidden confidence, or is caution warranted?

See what the numbers say about this price — find out in our valuation breakdown.

NYSE:UNF PE Ratio as at Dec 2025
NYSE:UNF PE Ratio as at Dec 2025

Build Your Own UniFirst Narrative

If you want to test these views against your own analysis or dive deeper into the data, UniFirst gives you the tools to build a personal case in just a few minutes. Do it your way

A good starting point is our analysis highlighting 2 key rewards investors are optimistic about regarding UniFirst.

Looking for More Smart Investment Ideas?

Smart investors never settle for just one angle. Expand your opportunities with these fresh, data-driven strategies tailored to today’s market. You could be missing out if you stop here.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.